Posted in | News | Business

Limtech to Acquire Key Parts of Its Competitor

Nov 5 2002

Related Stories

Lithium Metal Technology Inc, Limtech have signed a letter of intent to acquire key lithium carbonate assets from its principal competitor ILiON Technology. The acquisition of goodwill and technology will cost Limtech approximately US$600,000.

Limtech are excited about the acquisition as it will consolidate their position as the world leader in the lithium carbonate market.

ILiON have also developed a high quality lithium carbonate related technology with excellent commercial potential. They also possess a diversified global client-base which will compliment that of Limtech.

ILiON will continue to develop other technologies not related to lithium carbonate after the conclusion of the transaction.

For more information on lithium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback